CORRECT: AstraZeneca, Daiichi make US progress with licence approvals
(Correcting the description of extravascular haemolysis’ effects on patients with paroxysmal nocturnal haemoglobinuria)
AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments...
Wed, 03/04/2024 - 11:02